BAP1 and lung carcinoma: Another issue that needs to be addressed is the levels of miR-31 in lung cancer tissues: are the 1.5-2 fold increases of miR-31 levels detected in Figure 1 sufficient to reduce the expression of BAP1 protein in vivo?